144 related articles for article (PubMed ID: 5861252)
1. The renal excretion of urate in chronic lead nephropathy.
Emmerson BT
Australas Ann Med; 1965 Nov; 14(4):295-303. PubMed ID: 5861252
[No Abstract] [Full Text] [Related]
2. Gout and crystal-related nephropathy.
Cameron JS; Simmonds HA
Contrib Nephrol; 1979; 16():147-53. PubMed ID: 467064
[No Abstract] [Full Text] [Related]
3. Requiem for gouty nephropathy.
Beck LH
Kidney Int; 1986 Aug; 30(2):280-7. PubMed ID: 3761864
[No Abstract] [Full Text] [Related]
4. The role of lead in gout nephropathy.
Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP
N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160
[No Abstract] [Full Text] [Related]
5. [Uricosuric agent].
Ohno I
Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
[TBL] [Abstract][Full Text] [Related]
6. Renal handling of urate in healthy man in hyperuricaemia and renal insufficiency: circadian fluctuation, effect of water diuresis and of uricosuric agents.
Lang F; Greger R; Oberleithner H; Griss E; Lang K; Pastner D; Dittrich P; Deetjen P
Eur J Clin Invest; 1980 Aug; 10(4):285-92. PubMed ID: 6775956
[TBL] [Abstract][Full Text] [Related]
7. Moonshine and lead. Relationship to the pathogenesis of hyperuricemia in gout.
Reynolds PP; Knapp MJ; Baraf HS; Holmes EW
Arthritis Rheum; 1983 Sep; 26(9):1057-64. PubMed ID: 6412722
[No Abstract] [Full Text] [Related]
8. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
Orfanos CE; Künzig M
Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
[TBL] [Abstract][Full Text] [Related]
9. The relative contributions of tubular reabsorption and secretion to urate excretion in lead nephropathy.
Emmerson BT; Mirosch W; Douglas JB
Aust N Z J Med; 1971 Nov; 1(4):353-62. PubMed ID: 5292992
[No Abstract] [Full Text] [Related]
10. Hyperuricemia, acute gout, renal insufficiency and urate nephrolithiasis due to starvation.
Drenick EJ
Arthritis Rheum; 1965 Oct; 8(5):988-97. PubMed ID: 5863113
[No Abstract] [Full Text] [Related]
11. Lead nephropathy, gout, and hypertension.
Batuman V
Am J Med Sci; 1993 Apr; 305(4):241-7. PubMed ID: 8475950
[TBL] [Abstract][Full Text] [Related]
12. Control of uric acid excretion.
Steele TH
N Engl J Med; 1971 May; 284(21):1193-6. PubMed ID: 4929385
[No Abstract] [Full Text] [Related]
13. Hyperuricemia and gout. Classification, complications and management.
Boss GR; Seegmiller JE
N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806
[No Abstract] [Full Text] [Related]
14. Uricosuric therapy and urate solubility in blood and urine.
Gröbner W; Zöllner N
Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
[TBL] [Abstract][Full Text] [Related]
15. Gout, uric acid and renal disease.
Emmerson BT
Med J Aust; 1976 Mar; 1(12):403-5. PubMed ID: 1272125
[TBL] [Abstract][Full Text] [Related]
16. [Lead gout with giant tophi under the skin, nephropathy and porphyrinopathy].
Künzig M; Orfanos CE
Z Hautkr; 1977 Mar; 52(6):346-7. PubMed ID: 860554
[No Abstract] [Full Text] [Related]
17. Gout secondary to chronic renal disease: studies on urate metabolism.
Sorensen LF
Ann Rheum Dis; 1980 Oct; 39(5):424-30. PubMed ID: 7436573
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia and gout.
German DC; Holmes EW
Med Clin North Am; 1986 Mar; 70(2):419-36. PubMed ID: 3512932
[TBL] [Abstract][Full Text] [Related]
19. [Kidney tubular transport disorders. Disorders of renal urate transport].
Fujimori S; Yamanouchi T; Kaneko K; Akaoka I
Nihon Rinsho; 1989 Jul; 47(7):1597-602. PubMed ID: 2810812
[No Abstract] [Full Text] [Related]
20. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
Mangini RJ
Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
[No Abstract] [Full Text] [Related]
[Next] [New Search]